Vamil Divan Initiated (ABBV) at Buy and Held Target at $54 on, Oct 8th, 2013
Vamil Divan of Credit Suisse, Initiated "AbbVie Inc." (ABBV) at Buy and Held Target at $54 on, Oct 8th, 2013.
Vamil has made no other calls on ABBV in the last 4 months.
There is 1 other peer that has a rating on ABBV. Out of the 1 peers that are also analyzing ABBV, 0 agree with Vamil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vamil
- David Toung of "Argus Research" Initiated at Strong Buy on, Monday, August 12th, 2013
Similar House and Home Articles
[ Fri, Sep 27th 2013
] - WOPRAI
[ Mon, Sep 23rd 2013
] - WOPRAI
[ Tue, Sep 17th 2013
] - WOPRAI
[ Tue, Jun 18th 2013
] - WOPRAI
[ Wed, Apr 24th 2013
] - WOPRAI
[ Wed, Apr 03rd 2013
] - WOPRAI
[ Mon, Apr 01st 2013
] - WOPRAI
[ Mon, Mar 11th 2013
] - WOPRAI
[ Wed, Jan 02nd 2013
] - WOPRAI
[ Thu, Nov 08th 2012
] - WOPRAI